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Background: Telehealth is increasingly used in the care of people with long term conditions. Whilst many studies
look at the impacts of the technology on hospital use, few look at how it changes contacts with primary care
professionals. The aim of this paper was to assess the impacts of home-based telehealth interventions on general
practice contacts.
Method: Secondary analysis of data from a Department of Health funded cluster-randomised trial with 179 general
practices in three areas of England randomly assigned to offer telehealth or usual care to eligible patients.
Telehealth included remote exchange of vitals signs and symptoms data between patients and healthcare
professionals as part of the continuing management of patients. Usual care reflected the range of services
otherwise available in the sites, excluding telehealth. Anonymised data from GP systems were used to construct
person level histories for control and intervention patients. We tested for differences in numbers of general
practitioner and practice nurse contacts over twelve months and in the number of clinical readings recorded on
general practice systems over twelve months.
Results: 3,230 people with diabetes, chronic obstructive pulmonary disease or heart failure were recruited in 2008
and 2009. 1219 intervention and 1098 control cases were available for analysis. No statistically significant differences
were detected in the numbers of general practitioner or practice nurse contacts between intervention and control
groups during the trial, or in the numbers of clinical readings recorded on the general practice systems.
Conclusions: Telehealth did not appear associated with different levels of contact with general practitioners and
practice nurses. We note that the way that telehealth impacts on primary care roles may be influenced by a
number of other features in the health system. The challenge is to ensure that these systems lead to better
integration of care than fragmentation.
Trial registration number: International Standard Randomised Controlled Trial Number Register ISRCTN43002091.
Keywords: Telemedicine, Telemonitoring, General practice, Workload, Chronic diseaseBackground
The use of telehealth to allow patients with long-term
health conditions to monitor vital signs and transfer
readings to health professionals working remotely is in-
creasingly being advocated as a way of delivering higher
quality care more efficiently for better management of
people with long term conditions [1]. Very often, one of
the benefits of telehealth is perceived to be its potential* Correspondence: martin.bardsley@nuffieldtrust.org.uk
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reproduction in any medium, provided the orimpact on the use of hospital care. Relatively little atten-
tion has been placed on its impacts on primary care ser-
vices such as general practices. Yet these are important
determinants of patient experience and quality of care
and the costs of providing primary and community
health care to populations with long-term health condi-
tions can be almost as large as hospital costs [2]. The
impact of these technologies on primary care is therefore
an important element in understanding the opportun-
ities and potential barriers to introducing telehealth [3].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Eligibility for the trial
Practice
characteristics
All practices within the geographical areas covered by
the sites (Cornwall, Newham and Kent) were eligible
and were invited to participate in the trial by letter.
Each practice that accepted the invitation to
participate was allocated to an intervention or control
group via a centrally-administered minimisation
algorithm that aimed to ensure that the groups of
practices were similar in terms of practice size,
deprivation index, proportion of non-white patients,
prevalence of diabetes, COPD and heart failure, and
site (Cornwall, Kent and Newham).
Patient
characteristics
Within each practice, patients aged 18 or over were
deemed eligible on the basis of a diagnosis in
primary or secondary care for COPD, heart failure or
diabetes.
Eligibility was not conferred on the basis of formal
clinical assessment of disease severity. Instead
patients were deemed eligible on the basis of either
(i) their inclusion on the relevant Quality Outcomes
Framework register in primary care, (ii) a confirmed
medical diagnosis in primary or secondary care
medical records as indicated by general practice Read
Codes or ICD-10 codes, or (iii) confirmation of disease
status by a local clinician (i.e. general practitioner or
community matron) or by their hospital consultant.
Patients were not excluded on the basis of additional
physical co-morbidities. However, the patient’s home
had to be suitable for the installation of telehealth.
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pact of telehealth on primary care. First, telehealth might
reduce the need for support from primary care; for ex-
ample, because problems are detected earlier, patients
develop better self-care skills, or there is less need to
undertake measurements such as weight in general prac-
tice. Telehealth may also serve to buffer the general
practice in situations where the professionals who are
monitoring patients as part of the telehealth service are
distinct from general practice and have the authority to
provide clinical care, for example by adjusting treatment
and/or reassuring patients. In some instances, the pa-
tient contact may go directly to the hospital consultant
[4]. Conversely, telehealth might increase the need for
support from primary care, if the extra clinical information
obtained through telehealth prompts calls for intervention
from professionals. This could be due to abnormal read-
ings that would in the absence of monitoring have returned
to a normal range; or due to heightened awareness from
patients.
Few studies have addressed the impact of telehealth on
primary care. Some small studies have observed indications
of time savings for general practices [5,6] and one noted a
non significant reduction in home nursing visits and a re-
duction in hospital admission [7]. A randomised trial of 40
patients’ with moderate to severe Chronic Obstructive Pul-
monary Disease (COPD) found that telemonitoring did not
change the rate of emergency hospital visits but did reduce
primary care contacts for chest problems [8]. A more re-
cent randomised trial of remote blood pressure monitoring
in 401 patients with hypertension found improved control
of blood pressure but increased general practitioner and
nurse consultations [9,10]. The Whole Systems Demon-
strator programme aimed to address weaknesses in the evi-
dence base for the effectiveness of telehealth in people with
COPD, heart failure and diabetes, through a wide-ranging
evaluation in three sites in England, UK (Cornwall,
Kent and Newham) [11]. Over 3,000 patients were
recruited and received telehealth or usual care on the
basis of randomised allocations made at the general
practice level. The first published results showed fewer
urgent and unplanned (‘emergency’) hospital admis-
sions among telehealth patients than usual-care con-
trols [12], though this appeared to have been linked
with increases in emergency admissions among the
control group following the start of the trial. Overall
savings through reduced hospital activity over one year
were not statistically significant. Though reduced mor-
tality rates were seen, there was no overall improve-
ments in quality of life among survivors [13], and the
intervention was not found to be cost effective at realis-
tic willingness-to-pay thresholds [2].
In this paper, we describe secondary analysis of the
General Practice (GP) data sets amassed for the WholeSystems Demonstrator evaluation. The focus here is on
the impact of telehealth on primary care physicians
(general practitioners) and on nurses based in general
practices (practice nurses). To assess this we compared
changes between intervention and control groups in
terms of the frequency of visits to general practitioners
and practice nurses. We also addressed the number of
times clinical readings relevant to the management of
patients were recorded on the general practice systems.
Methods
The protocol for the Whole Systems Demonstrator
evaluation has previously been described and included
plans to undertake secondary analysis of primary care
use [11,12]. The study randomised general practices to
offer either telehealth or usual care to eligible patients
(criteria in Table 1) with COPD, diabetes or heart failure.
Control patients received usual care and were offered
telehealth at the end of the twelve-month trial period if
they were still eligible at that point.
Telehealth intervention
The pragmatic trial design meant that there was flexibil-
ity for local teams to develop their own telehealth ser-
vices. Therefore, choices of telehealth devices and
monitoring systems varied between the three trial sites
and there was no attempt to standardise across sites.
Sites used different protocols for allocating peripheral
devices but across all sites the critical devices per
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cose monitors (for diabetes) and weighing scales (for
heart failure). In addition, almost all intervention partici-
pants received blood pressure monitors. Participants
were asked to take clinical readings up to five days per
week at the same time each day. In addition symptom
questions and educational messages were transmitted to
participants, either via the telehealth base unit or using
a set-top box connected to a television. At the end of
each session, data were transmitted to monitoring cen-
tres via secure servers. These centres were staffed by
local health organisations. Sites used a variety of ap-
proaches to respond to triggers generated by worsening
patterns in telehealth readings. These ranged from an
approach based on locating specialist nurses in monitor-
ing centres to routing alerts to community-based staff,
such as community matrons. In one of the two Kent Pri-
mary Care Trusts, warning signs from telehealth were
routed direct to general practices for their response.
Data sets
Information about service activity was derived from
extracts from operational information systems and in
particular exploiting the system of coded data on
computerised general practice systems. Though there
are national standard coding systems available and
widely used, there can be differences between practices
in the specify codes used. All general practices partici-
pating in the trial were asked to share data for the
whole of their adult practice population, including
registration and encounter dates, diagnoses, test results
and prescriptions. Data were “pseudonymised” before be-
ing transferred to the research team, so that patient-
identifiable fields could be removed and a unique patient
identifier (the “NHS number”) encrypted. Pseudonymised
NHS numbers were used to link the general practice data
to hospital data sets which included information on in-
patient stays, outpatient attendances and emergency visits.
The research team created person-level data sets to
summarise all key health care contacts experienced by
the participants over several years. The approach of
using pseudonyms in secure environments is regarded
by the National Information Governance Board as ap-
propriate technique for these types of study where pa-
tient consent across a whole population is not feasible.
The study was approved by Liverpool Research Ethics
Committee (ref: 08/H1005/4).
Study cohort and end points
This study was restricted to participants (linked to GP
data) that were enrolled into the trial before the planned
recruitment termination date (30 September 2009). The
trial enrolment date was taken as the date of telehealth
installation for intervention patients, and as the date ofthe initial project team visit for controls. Further, we re-
quired that patients had a continuous prior record of
registration with general practices within the data sets,
spanning the two years prior to the trial and the period
of the trial itself (excluding patients that died).
Analysis was based on comparing activity over
12 months from the enrolment dates, at the person level.
General practice workload was based on the number of
contacts with a principal general practitioner, locum or
registrar (coded as staff types A, B or C); and practice
nurses in primary care (staff type D06). In both cases,
contacts were obtained from the computerised practice
systems and included all locations (GP Surgery, Home
Visit, Telephone etc.). We also studied the number of
times test results were recorded within the general prac-
tice records specifically for glycosylated haemoglobin
A1C, weight, blood oxygen levels and respiratory flow
(relevant Read codes in Additional file 1). These metrics
were chosen as they were akin to the readings that were
regularly made by patients receiving telemonitoring. A
variable was created based on the count of different
readings obtained per person.
Statistical analysis
We examined the similarity of intervention and control
patients at baseline using the standardised difference, de-
fined as the difference in sample means as a proportion of
the pooled standard deviation [14]. Previous studies have
used a standardised difference of 10% as a threshold to de-
note meaningful difference in baseline variables [15].
To provide information on the generalisability of trial
results, we tested for differences between the general
practice contact rates of trial participants and those of
the wider adult population (among the practices that
provided data for the evaluation). In this analysis, these
comparisons were based on the number of contacts in
2009/10 and were adjusted for age band and sex using
Poisson regression. As not all patients were alive and
registered with a practice for the whole of the 2009/
10 year, we annualised rates by including an offset in the
Poisson regression.
Individuals were analysed on an “intention-to-treat”
basis, i.e. based on the randomised treatment allocations
of the general practices, and regardless of subsequent
withdrawal from the trial. We used two methods to
compare intervention and control groups. The first used
a difference-in-difference method to assess whether the
number of contacts and recorded clinical readings in-
creased more quickly or more slowly among the inter-
vention group than controls, from the year before
enrolment to the year after. This was done using ordin-
ary least squares regression, with the output relating to
an absolute number of admissions. The second analysis
made a direct comparison of numbers of contacts and
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trial period. This was done using Poisson regression,
with exponentiation of the model coefficients producing
an incidence rate ratio. As in the primary analysis [12],
three versions of the incidence rate ratio were produced,
with different forms of case-mix adjustment (Table 2).
We expected that contact rates would be more highly
correlated for patients registered at the same practice
than at different practices. Therefore, all of our models
reflected intracluster correlation at the practice level,
using multilevel models with random effects at the prac-
tice level [17].Results
Patient recruitment
249 out of 254 practices agreed to share routine data from
their systems for the evaluation, although data extraction
was not possible for a further 5 practices for technical rea-
sons linked with the clinical operating systems used. The
data sets obtained spanned more than four years (April
2006 to September 2010) and contained almost one billion
records. Ultimately, 1,625 control and 1,605 interventionTable 2 Three forms of case-mix adjustment used in
analysis
Unadjusted The simplest models, although accounting for the effect
of clustering, used no additional case-mix adjustment.
Adjusted These models additionally controlled for residual
imbalances in a set of baseline characteristics. This set
included age, sex, ethnicity, site, number of chronic health
conditions, principal long-term condition (diabetes,
chronic obstructive pulmonary disease or heart failure), an
area-based socioeconomic deprivation score (national
quartiles of the Index of Multiple Deprivation 2007), and a
metric corresponding to the endpoint (e.g., general
practitioners contacts) calculated over several periods
within the two years prior to recruitment.
The number of chronic health conditions was a count of
diagnoses recorded on inpatient data over the three
years prior to starting the trial. Principal long-term
conditions were assigned using a pragmatic approach
according to published criteria [16].
Combined
model
More complex case-mix adjustment was conducted using
the Combined Predictive Model [16] a standard
instrument designed to estimate the probability that an
individual will experience an emergency hospital
admission in a future twelve month period. The Combined
Model score uses 72 variables covering age, sex, recorded
health conditions, prior hospital use and prescribing, but
not primary care contacts. These variables are sourced
from general practice and hospital administrative data.
Where a general practice did not grant approval to extract
data for the evaluation, or where scores could not be
calculated, scores were imputed for its patients based on
the available information, which included age, sex and the
hospital variables. Single imputation was used based on
linear regression on the logit scale. When used in the case-
mix adjustment, the Combined Predictive Model score
was calculated for each participant at the end of the
month prior to the start date.patients were recruited into the telehealth part of the trial
from 179 general practices (for full Consort flow diagram
see Steventon et al. [12]).
The analysis of general practice use was restricted to
1,219 intervention and 1,098 control participants recruited
before September 2009 and with a continuous general
practice registration (76% of intervention patients and 68%
of controls). Excluded participants were not statistically dif-
ferent from those included in terms of age at baseline, sex
and number of chronic conditions. However, included par-
ticipants were more likely to come from Newham (31.0%
of included patients compared with 26.7% of the overall
sample), and from the 20% most socioeconomically de-
prived areas (21.4% of patients compared with 19.5%). Of
patients included, a full Combined Predictive Model score
could be computed for 2,238 patients (96.6%); scores were
imputed for the remainder using the method described in
Table 2.
The routine data sets showed that, among the general
population in 2009/10, the consultation rates for trial
participants were higher than the general population (in-
cidence rate ratio 2.00, p < 0.001) and showed no clear
trend by age. Similar patterns were found for practice
nurse contacts (incidence rate ratio 1.97, p < 0.001).
Baseline differences
Intervention and control patients were similar at base-
line (Table 3), with only a few standardised differences
greater than 10%. The largest standardised differences
related to the proportion of people living in the most so-
cioeconomically deprived fifth of the population (8.7%
intervention and 5.1% of controls, standardised differ-
ence 14.3%) and to long-term health conditions (27.1%
of intervention patients had diabetes as their principal
condition compared with 22.6% of controls, standardised
difference 10.4%).
Before the start of the trial, rates of general practi-
tioner contact were similar for the intervention and con-
trol groups, at around one visit every 6 weeks (8.8 vs. 9.0
visits per person per year, standardised difference 2.0%).
Some patients (constituting 8.1% of control patients)
had over 20 visits with a general practitioner during the
year before the start of the trial, while 4.5% had no
recorded contacts on general practice information sys-
tems. The average number of practice nurse contacts
during the year before enrolment was slightly lower in
the intervention than control group (5.3 contacts per
person per year versus 6.1, standardised difference
10.2%). Over both groups 15.2% of patents had no
recorded practice nurse contacts whilst 5.3% of partici-
pants had over 20 contacts in the year before the start of
the trial.
Figure 1 shows trends in general practitioner and prac-
tice nurse contacts by month, without adjusting for
Table 3 Baseline characteristics of intervention and




Number in group 1098 1219









Diabetes 22.6 27.1 10.4




1.9 (1.8) 1.8 (1.8) −3.9
Site
Cornwall 32.6 36.5 8.2
Kent 36.2 32.7 −7.2
Newham 31.2 30.8 −1.0
Age (mean (SD)) 70.8 (11.8) 69.7 (11.6) −9.3
Aged under 65 28.7 30.1 3.1
Aged 65-74 31.4 34.9 7.5
Aged 75-84 30.9 27.4 −7.7
Aged 85+ 9.0 7.5 −5.3
Female (%) 40.4 41.1 1.3
Ethnicity
White 71.3 71.8 1.0
Non-white 13.2 12.3 −2.7
Unknown 15.5 15.9 1.2
Area-level deprivation
(mean (SD))*
29.8 (13.8) 28.8 (14.9) −6.9
1st quartile 5.1 8.7 14.3
2nd quartile 15.4 15.5 0.2
3rd quartile 31.8 32.6 1.9
4th quartile 47.7 43.2 −9.2
GP visits per person
(prior year) (mean (SD))
9.0 (7.6) 8.8 (6.8) −2.0
None 4.5 3.5 −4.8
1-5 35.2 33.1 −4.6
6-10 29.0 30.5 3.4
11-20 23.2 26.4 7.4
>20 8.1 6.5 −6.3
Practice nurse contacts
per person (prior year)
(mean (SD))
6.1 (8.1) 5.3 (7.8) −10.2
None 14.8 15.5 2.1
1-5 51.1 57.1 12.1
6-10 16.4 14.8 −4.5
Table 3 Baseline characteristics of intervention and
controls groups (data are % of group unless otherwise
specified) (Continued)
11-20 11.9 7.8 −13.9
>20 5.8 4.8 −4.4
Combined Model
score (mean (SD))**
27.0 (20.2) 26.1 (20.1) −4.3
Low risk 14.6 15.9 3.5
Moderate risk 30.0 32.1 4.5
High risk 44.3 41.6 −5.6
Very high risk 11.1 10.5 −1.9
SD = Standard deviation.
*n(controls) = 1096, n(intervention = 1214). First quartile is least deprived,
fourth quartile is most deprived.
**n(controls) = 1,047; n(intervention) = 1,191. Risk categories denote top
proportions of site population: very high risk (0.5%), high risk (0.5-5%),
moderate risk (5-20%), and low risk (20-100%).
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were stable before the start of the trial. During the
12 months of the trial, the number of visits fell slightly
for the whole cohort. However, a number of patents died
during the 12 months (4.9% of intervention patients in-
cluded in this sample, compared with 9.1% of controls in
the sample). The average quarterly rate of general practi-
tioner contacts for survivors was 2.14 for intervention
patients at the end of the trial and 2.26 for controls.
Mortality may therefore explain some of the slight fall in
visits.Analyses of differences in contact rates during the trial
period
As previously stated, the difference-in-difference analysis
and Poisson regressions took clustering into account;
the intracluster correlation coefficient (ICC) for general
practitioner contacts was estimated to be 0.184.
During the 12 month trial period, the number of gen-
eral practitioner contacts in the intervention group
(mean 8.99, standard deviation 7.00) was similar to that
in the control group (mean 8.85, standard deviation
8.16), see Table 4. When compared with the contacts
during the 12 months before the trial started, the
difference-in-difference estimate indicated that contacts
rose more quickly among the intervention than control
group, by 0.29 contacts per head. However, this was not
statistically significant (p=0.465) with an adjusted inci-
dence rate ratio was 1.04 (95% confidence interval, 0.95
to 1.30, Table 5). Differences did not reach statistical sig-
nificance after case-mix adjustment using Poisson re-
gression. While the estimates for rise in contacts were
higher for practice nurses than for general practitioners
(difference-in-difference estimate 0.45 contacts per head;
Figure 1 Crude monthly rates of contact.
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they were not statistically significant.
The number of clinical readings summed across the
four clinical domains was similar between intervention
and control groups in the 12 months before the trial
(2.73 versus 2.67 readings per person). The difference-
in-difference estimate indicated that the number of
readings increased more quickly among the interven-
tion than control group (by 0.11 readings per head) but
this was not statistically significant (p=0.414). The ad-
justed Poisson analysis reported very similar rates of
clinical readings during the twelve months of the trial
(adjusted incidence rate ratio 1.00, 95% CI, 0.90 to 1.12,
p=0.931).Table 4 Unadjusted rates of contacts and readings (figures ar
Before
Control Intervention C
GP contacts 8.98 (7.61) 8.84 (6.76) 8.8
Practice nurse contacts 6.07 (8.07) 5.26 (7.76) 6.2
Clinical readings* 2.76 (2.59) 2.73 (2.47) 2.7
*based on number of recordings of HbA1c, weight, blood oxygen, respiratory flow.Discussion
Summary
This study addressed a weakness in the evidence base
about the impact of telehealth on primary care by
exploiting operational data sets from 179 general prac-
tices. On average, over the twelve months before the
start of the Whole Systems Demonstrator trial, partici-
pants had 8–9 consultations with general practitioners,
which was substantially higher than for the general
population of the three sites during 2009/10 and more
consultations than reported in other studies for people
of a similar age [18].
We found no evidence to support the theory that
telehealth alters rates of contact with general practices.e numbers per patient over twelve months (SD))
After Difference-in-difference
ontrol Intervention Estimate P
5 (8.16) 8.99 (7.00) 0.29 0.465
8 (8.98) 5.92 (9.83) 0.45 0.245
1 (2.53) 2.80 (2.76) 0.11 0.414




Model Estimate (95% CI) P
General practitioner
contacts
Unadjusted 1.05 (0.90 to 1.23) 0.520
Adjusted 1.04 (0.95 to 1.14) 0.404
Combined
model
1.04 (0.90 to 1.21) 0.560
Practice nurse contacts Unadjusted 1.14 (0.81 to 1.61) 0.438
Adjusted 1.04 (0.82 to 1.30) 0.756
Combined
model
1.13 (0.81 to 1.58) 0.468
Clinical readings* Unadjusted 1.01 (0.85 to 1.20) 0.881
Adjusted 1.00 (0.90 to 1.12) 0.931
*based on number of recordings of HbA1c, weight, blood oxygen,
respiratory flow.
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ated with an increase of 4% in general practitioner con-
sultations but this was not statistically significant on this
sample. We also found no changes in the frequency with
which clinical measurements such as weight, HbA1c,
blood oxygen and respiratory flow were recorded on the
general practice records. Given the frequency with which
patients themselves recorded similar measurements
using telehealth equipment (up to five times per week),
our findings may indicate scope to improve the integra-
tion of information systems and care between the
telehealth intervention and general practice.
Strengths and limitations
This particular study is part of a wider evaluation of the
Whole Systems Demonstrator programme, which ad-
dresses a wider range of outcomes than in this paper.
We hypothesised that telehealth could act in two oppos-
ing ways: either to increase or reduce the need for rou-
tine contact - though we found no overall effect it may
be these two effects occurred but offset each other. Al-
ternatively, it is possible that the impact of telehealth on
workload was not manifested simply in the numbers of
consultations but may be in the nature of consultations.
For example, the content of general practice encounters
might have changed following introduction of telehealth,
even if the number of overall contacts did not change.
This study (with 2,317 patients included in the ana-
lysis) was much larger than the previous hypertension
trial (which recruited 401 patients) [9]. However, it is
possible that issues of sample size have contributed to
the lack of statistical significance of the findings; we note
we cannot rule out changes as great as a 10% reduction
in general practitioner contacts or a 23% increase.
We relied on pre-existing, routine data sets. This has
benefits over the alternative approach using self-
reported data from patients, as patients do not alwaysrecall the use of health services accurately, particularly
when it comes to events with low ‘salience’ including
many general practice visits [19]. However, using
existing administrative or clinical data sets may also
bring problems with the completeness of data [20,21].
For example, problems with the completeness of coding
meant that we were not able to separate surgery consul-
tations from home visits. Similarly it may be that some
tests may have stayed as written comments in the notes,
and not been coded on the computer systems.
In a cluster-randomised trial there is a risk of selection
bias. Although patients were blinded to treatment alloca-
tions until after they had consented to participate, it was
not possible in this trial to guarantee that those people
recruiting patients were always blinded. Therefore, there
is a risk that patients with certain characteristics might
be preferentially recruited into either the control or the
intervention arm. We were reassured that we could ob-
serve few large differences between the characteristics of
intervention and control patients at baseline, though as
previously noted the number of participants per practice
differed for intervention and control practices (medians
8.5 and 12). We were able to adjust for observed base-
line characteristics using several forms of case-mix ad-
justment, and also applied a difference-in-difference
estimator.
The study aimed to address a broad class of telehealth
devices and did not aim to address specific devices and
monitoring systems. Therefore these findings reflect a
routine introduction of telehealth, which differed be-
tween sites based on a series of decisions by local teams.
Thus, the monitoring systems used by the sites involved
general practice staff to varying extents. Although this
plurality may be seen as problematic to those wanting to
replicate specific aspects of the interventions, in some
ways it is the merit of a pragmatic trial as it meant we
could reflect implementation decisions made by local
teams.
The large, multicentre nature of this trial should im-
prove the generalisability of the trial results. However,
the patients and health care professionals who agree to
participate in randomised controlled trials may differ
from those who would use telehealth in routine clinical
practice [22]. In this study, the participants were higher
users of general practice services than other adult pa-
tients, but this was expected given that eligible patients
had a long-term condition. A qualitative study that
interviewed eligible patients who refused to participate
in this trial found three broad reasons, including issues
relating to the technology, self-care plans and perceived
threats to existing services [23]. Also of interest is
whether either of the treatments received in this trial
(telehealth or control) might have differed from those of-
fered in routine clinical practice. We note that staff in
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of the trial constrained them, so that they were not able
to innovate and improve the design of the telehealth trial
in response to learning [24]. Further, telehealth devices
are changing, and may have different impacts according
to the nature of the surrounding services and context.
Thus, the impact of telehealth in other settings might
differ from that reported in this study.
The initial analysis of hospitalisation data found that
emergency hospital admission rates appeared to increase
for the control group following enrolment [12]. This
leads us to suggest that either the trial protocol changed
the management of patients allocated to this group, or
that control patients may have reacted to their alloca-
tions, leading them to seek more care at the accident
and emergency department. We note that, in the current
study, we did not see a corresponding increase in gen-
eral practice visits.
Comparison with existing literature
Most studies of telehealth that address impacts on ser-
vice use focus on hospital activity [25]. Up until recently,
studies that looked at primary care tended to focus on
specific populations or issues, such as mental health
problems or geographically-dispersed communities. The
few studies that have considered similar forms of
telehealth to those tested in this trial, have often
reported more positive findings than here. For example,
a feasibility study in 20 elderly patients indicated a time
saving for the GP [6], while a study of home
telemonitoring in heart failure patients found reductions
in use of clinic visits [26]. However these studies were
much smaller than this trial and for this reason may
have recruited unrepresentative patients. Wade and col-
leagues commented on how telehealth alerts prompted
frequent contacts and increased the case managers’
workload [27]. A recent randomised study of telehealth
in hypertension found approximately one additional GP
surgery consultation and half a practice nurse surgery
consultation per person in the intervention group com-
pared with the usual care group [9], though in that study
general practice teams were more directly involved with
the telemonitoring than in the current study.
Implications
This study used linked operational data for large
numbers of patients, a method that has considerable po-
tential for future studies especially those that use retro-
spective analyses. The lack of observed impacts of
telehealth suggests that fears about increases in general
practice workload may be unfounded, at least when it
comes to workload for clinical staff as measured by the
number of contacts. The absence of any statistically-
significant effects will not by itself provide a financial orworkload incentive for primary care to deliver telehealth.
However, under recent changes to the NHS, clinical
commissioning groups including primary care profes-
sionals may have a firmer financial incentive to prevent
hospital admissions.
Telehealth may have different impacts on general
practice workload if designed differently. For example,
we note that many of the measures captured by
telehealth are recorded by general practices (such as
weight and blood oxygen levels). In theory, this means
there is potential for some work to be shifted from clin-
ical staff to patients. However, we did not find that these
readings were recorded in general practices any less fre-
quently among the intervention group. Better information
systems and higher general practice engagement might
lead to more impressive changes. We note however, that
clinical guidelines require some of these readings to be
recorded in general practice and remuneration systems
track the number of such measurements that are made.
For diabetes, HbA1c is recognised as a more stable meas-
ure than blood glucose. This illustrates how the conse-
quences of new technology depend on the wider health
systems, and not only on the attributes of the technology
itself.
Conclusions
In this study, the use of home based telehealth for people
with chronic disease did not appear associated with
changes in the frequency with which people contacted gen-
eral practitioners and practice nurses. This suggest that
fears that the widespread increase in the use of this technol-
ogy may increases the burden on primary are unfounded.
Conversely, we did not find evidence that telehealth led to
a significant reduction in GP workload. We note that the
way that telehealth impacts on primary care roles may be
influenced by a number of other features in the health sys-
tem. The challenge is to ensure that these systems lead to
better integration of care than fragmentation.
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